mRNA-3704
Methylmalonic Acidemia
Phase 1/2Active
Key Facts
About Moderna
Moderna, Inc. is a biotechnology company that harnesses the fundamental role of mRNA to translate genes into proteins to develop a new generation of transformative medicines for patients. The company created one of the most effective COVID-19 vaccines and has built a diverse development pipeline of mRNA medicines across multiple therapeutic areas. Moderna's platform approach enables rapid development of new treatments and vaccines by programming cells to produce therapeutic proteins.
View full company profile